» Articles » PMID: 34054912

Case Report: A Variant Non-ketotic Hyperglycinemia With Mutations: Manifestation of Deficiency of Activities of the Respiratory Chain Enzymes

Overview
Journal Front Genet
Date 2021 May 31
PMID 34054912
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Variant non-ketotic hyperglycinaemia (NKH) is a rare disorder characterized by variable clinical, biochemical, and imaging features. The variant form of NKH is rare and characterized by variable clinical, biochemical and imaging features. Herein, we report a girl with variant NKH with two mutations in glutaredoxin 5 (), which has been described in only three patients. The clinical and biochemical phenotypes of the patient are also described. She suffered from developmental regression associated with spasticity, developmental delay, anemia and optic atrophy. The mitochondrial leukoencephalopathy was used to designate these disorders. An increased T2 signal from the medulla oblongata to the C6 spinal region was also observed on spinal cord MRI. Tandem mass analysis of a dried blood sample revealed elevated levels of glycine. The patient has two compound heterozygous mutations (c.151_153 del AAG and c.196C>T) in the gene. The c.196C>T mutation led to a stop codon (p.Q66Ter). Activities of mitochondrial respiratory chain (MRC) complexes II+III in the patient's fibroblasts were abnormal. We present the case of a girl with variant NKH who manifested spasticity and bilateral cavitating leukoencephalopathy. The patient had a deficiency of a respiratory chain enzyme, and this is the first report. Genetic testing is important for physicians to evaluate suspected variant NKH patients and to provide proper genetic counseling.

Citing Articles

Case report: Unveiling genetic and phenotypic variability in Nonketotic hyperglycinemia: an atypical early onset case associated with a novel variant.

Marin V, Lebreton L, Guibet C, Mesli S, Redonnet-Vernhet I, Dexant M Front Genet. 2024; 15:1432272.

PMID: 39323869 PMC: 11422140. DOI: 10.3389/fgene.2024.1432272.


BOLA3 and NFU1 link mitoribosome iron-sulfur cluster assembly to multiple mitochondrial dysfunctions syndrome.

Zhong H, Janer A, Khalimonchuk O, Antonicka H, Shoubridge E, Barrientos A Nucleic Acids Res. 2023; 51(21):11797-11812.

PMID: 37823603 PMC: 10681725. DOI: 10.1093/nar/gkad842.


The Mutation Analysis of the AMT Gene in a Chinese Family With Nonketotic Hyperglycinemia.

Zhou B, Hui L, Zhang Q, Chen X, Zhang C, Zheng L Front Genet. 2022; 13:854712.

PMID: 35646099 PMC: 9133660. DOI: 10.3389/fgene.2022.854712.


GLRX5-associated [Fe-S] cluster biogenesis disorder: further characterisation of the neurological phenotype and long-term outcome.

Parayil Sankaran B, Gupta S, Tchan M, Devanapalli B, Rahman Y, Procopis P Orphanet J Rare Dis. 2021; 16(1):465.

PMID: 34732213 PMC: 8565018. DOI: 10.1186/s13023-021-02073-z.

References
1.
Baker 2nd P, Friederich M, Swanson M, Shaikh T, Bhattacharya K, Scharer G . Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5. Brain. 2013; 137(Pt 2):366-79. PMC: 3914472. DOI: 10.1093/brain/awt328. View

2.
Poothrikovil R, Al Thihli K, Al Futaisi A, Al Murshidi F . Nonketotic Hyperglycinemia: Two Case Reports and Review. Neurodiagn J. 2019; 59(3):142-151. DOI: 10.1080/21646821.2019.1645549. View

3.
Ogawa E, Shimura M, Fushimi T, Tajika M, Ichimoto K, Matsunaga A . Clinical validity of biochemical and molecular analysis in diagnosing Leigh syndrome: a study of 106 Japanese patients. J Inherit Metab Dis. 2017; 40(5):685-693. PMC: 5579154. DOI: 10.1007/s10545-017-0042-6. View

4.
Toone J, Applegarth D, Coulter-Mackie M, James E . Recurrent mutations in P- and T-proteins of the glycine cleavage complex and a novel T-protein mutation (N145I): a strategy for the molecular investigation of patients with nonketotic hyperglycinemia (NKH). Mol Genet Metab. 2001; 72(4):322-5. DOI: 10.1006/mgme.2001.3158. View

5.
Chiong M, Procopis P, Carpenter K, Wilcken B . Late-onset nonketotic hyperglycinemia with leukodystrophy and an unusual clinical course. Pediatr Neurol. 2007; 37(4):283-6. DOI: 10.1016/j.pediatrneurol.2007.05.016. View